Understanding Circuit Dynamics in Parkinson's Disease using Real-Time Neural Control
使用实时神经控制了解帕金森病的电路动力学
基本信息
- 批准号:10489840
- 负责人:
- 金额:$ 18.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-17 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
ABSTRACT (CATALYST PROJECT)
While much research has been dedicated to understanding the pathophysiology of Parkinson’s disease (PD),
the neural circuit dynamics underlying the manifestation of motor signs remain to be determined. Current theories
propose that the power and incidence of beta band (11-35 Hz) oscillations, synchronized throughout the basal
ganglia thalamocortical (BGTC) circuit, are associated with the severity of motor signs. Although changes in
bradykinesia and rigidity related to levodopa and deep brain stimulation (DBS) have been shown to correlate
with the power of local field potential (LFP) oscillations in the subthalamic nucleus (STN), no study has
deductively demonstrated their causal relationship. Clarifying whether this relationship is causal or
epiphenomenon is critical to advance our understanding of PD pathophysiology. The goal of this Catalyst
Project is to characterize the relationship of rigidity and bradykinesia with beta band oscillations and
their propagation dynamics in the BGTC circuit. We will leverage a new neural control approach capable
of suppressing or amplifying frequency-specific neural oscillations in real-time using DBS leads. This
technique, referred to as evoked-interference closed-loop DBS (eiDBS), is based on the concept that electrical
stimulation with precise amplitude and timing can evoke neural responses that modulate spontaneous neural
activity via constructive or destructive interference. We will characterize how controlled suppression or
amplification of beta band activity in the internal segment of the globus pallidus (GPi) or the STN via eiDBS
relates to the severity of rigidity and bradykinesia in PD patients. We will also test the hypothesis that changes
in the propagation of beta band oscillations (information flow) across the GPi, STN, motor (MC), premotor (PMC),
and dorsolateral prefrontal (DLPFC) cortices will be better correlated with rigidity and bradykinesia than the
amplitude of beta band oscillations alone (Aims 1,2). Furthermore, we will characterize the spectral, temporal,
and spatial dynamics of neural responses in the BGTC circuit evoked by stimulation in the GPi and STN. By
combining the evoked response (ER) data with high-resolution imaging and computational modeling, we will
delineate how activation of distinct neuronal pathways in the GPi and STN influences ER dynamics, critical not
only to optimize eiDBS, but also to provide insights into the mechanism(s) of action of DBS (Aim 3).
摘要(催化剂项目)
虽然许多研究致力于了解帕金森病(PD)的病理生理学,
运动信号表现背后的神经回路动力学仍有待确定。目前的理论
建议β波段(11-35 Hz)振荡的功率和发生率,在整个基底层同步
丘脑皮质神经节(BGTC)回路与运动体征的严重程度相关。虽然变化
与左旋多巴和脑深部电刺激(DBS)相关的运动迟缓和僵硬已被证明与
关于丘脑底核(subthalamic nucleus,简称NRN)局部场电位(local field potential,简称LFP)振荡的功率,
演绎地证明了它们之间的因果关系。澄清这种关系是否是因果关系,
副现象是至关重要的,以促进我们的理解PD的病理生理。该催化剂的目标是
该项目旨在描述刚性和运动迟缓与β带振荡的关系,
它们在BGTC电路中的传播动力学。我们将利用一种新的神经控制方法,
抑制或放大特定频率的神经振荡在实时使用DBS导线。这
一种称为诱发干扰闭环DBS(eiDBS)的技术,基于以下概念:
具有精确幅度和定时的刺激可以引起调节自发神经反应
通过相长干涉或相消干涉的活动。我们将描述如何控制抑制或
通过eiDBS扩增苍白球(GPi)或延髓内段中的β带活性
与PD患者的僵硬和运动迟缓的严重程度相关。我们还将检验假设,
在β波段振荡(信息流)在GPi、PMP 1、运动(MC)、前运动(PMC)
和背外侧前额叶(DLPFC)皮质与僵硬和运动迟缓的相关性比
单独的β波段振荡幅度(目标1、2)。此外,我们将描述光谱,时间,
和空间动力学的神经反应在BGTC电路中诱发的刺激在GPi和ESTA。通过
结合诱发反应(ER)数据与高分辨率成像和计算建模,我们将
描述了GPi和GPi中不同神经元通路的激活如何影响ER动力学,
不仅优化eiDBS,而且还提供DBS作用机制的见解(目的3)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joshua E Aman其他文献
Joshua E Aman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joshua E Aman', 18)}}的其他基金
Understanding Circuit Dynamics in Parkinson's Disease using Real-Time Neural Control
使用实时神经控制了解帕金森病的电路动力学
- 批准号:
10703251 - 财政年份:2021
- 资助金额:
$ 18.56万 - 项目类别:
相似海外基金
Human Dopamine Grafts in Alpha-Synuclein Models of Parkinson Disease
帕金森病α-突触核蛋白模型中的人多巴胺移植物
- 批准号:
10736403 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Effects of deep brain stimulation (DBS) on laryngeal function and associated behaviors in Parkinson Disease
深部脑刺激(DBS)对帕金森病喉功能和相关行为的影响
- 批准号:
10735930 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Determination of the clinical relevance of Parkinson disease-associated intronic enhancer of the alpha-synuclein gene, in a novel mouse deletion model
在新型小鼠缺失模型中确定帕金森病相关的α-突触核蛋白基因内含子增强子的临床相关性
- 批准号:
10665271 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Leveraging a Natural Experiment to Determine the Effects of Integrated Palliative Care on Health Service Outcomes and Disparities in Parkinson Disease and Lewy Body Dementia
利用自然实验确定综合姑息治疗对帕金森病和路易体痴呆的卫生服务结果和差异的影响
- 批准号:
10701322 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
An Integrated Biomarker Approach to Personalized, Adaptive Deep Brain Stimulation in Parkinson Disease
帕金森病个性化、适应性深部脑刺激的综合生物标志物方法
- 批准号:
10571952 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Parkinson Disease Neural Circuitry and Gastrointestinal Pathobiology
帕金森病神经回路和胃肠道病理学
- 批准号:
10740119 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Cerebellar cholinergic connections as a biomarker of dementia and gait impairment in Parkinson disease
小脑胆碱能连接作为帕金森病痴呆和步态障碍的生物标志物
- 批准号:
10351813 - 财政年份:2022
- 资助金额:
$ 18.56万 - 项目类别:
Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and Genetics
帕金森病的种族差异 - 临床表型、治疗和遗传学
- 批准号:
10346329 - 财政年份:2022
- 资助金额:
$ 18.56万 - 项目类别:
Characterization of Alpha-Synuclein Aggregation Using Parkinson Disease Patient-Derived Midbrain Organoids
使用帕金森病患者来源的中脑类器官表征 α-突触核蛋白聚集
- 批准号:
474479 - 财政年份:2022
- 资助金额:
$ 18.56万 - 项目类别:
Studentship Programs
Musical rhythm synchronization as a mechanism to optimize gait in the real-world in persons with Parkinson disease
音乐节奏同步作为优化帕金森病患者现实世界步态的机制
- 批准号:
10534030 - 财政年份:2022
- 资助金额:
$ 18.56万 - 项目类别: